Inventor
ANTHONY C. BLACKBURN
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds22%
C07BGeneral methods of organic chemistry13%
C07CAcyclic or carbocyclic compounds9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
PatentTitleYear
12,378,198Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders202512,109,219Cannabinoid receptor modulators202411,884,626Crystalline L-arginine salt of (202411,771,695Cannabinoid receptor modulators202311,560,369Crystalline forms and processes for the preparation of cannabinoid receptor modulators202311,560,386Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to ARENA PHARM INC (6)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARENA PHARM INC | 6 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2023–2025 |